Nact as a target for lifespan expansion and weight reduction

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 33/00 (2006.01) A61K 45/00 (2006.01) C07K 14/705 (2006.01) C07K 16/00 (2006.01) C07K 16/28 (2006.01) C07K 16/46 (2006.01) C12N 15/11 (2006.01) C12N 15/63 (2006.01) C12Q 1/02 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2506666

The present invention provides the identification and characterization of a novel transmembrane transporter, a Na+-coupled citrate transporter ("NaCT"). Isolated polynucleotides encoding the transmembrane transporter, the transmembrane transporter polypeptide itself, antibodies thereto, and methods of use, are provided.

L'invention concerne l'identification et la caractérisation d'un nouveau transporteur de transmembrane, à savoir d'un transporteur de citrate couplé à Na?+¿ ("NaCT"). L'invention concerne des polynucléotides isolés codant le transporteur de transmembrane, le polypeptide transporteur de transmembrane lui-même, des anticorps, et leurs procédés d'utilisation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nact as a target for lifespan expansion and weight reduction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nact as a target for lifespan expansion and weight reduction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nact as a target for lifespan expansion and weight reduction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1645514

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.